leaderboard
Type 1 diabetes
Mon, 2010-03-15 02:00 — sciencestaff
Type 1 diabetes (T1D), also termed juvenile-onset or insulin-dependent diabetes, is an autoimmune disease and a metabolic disorder characterized by T-cell-mediated destruction of pancreatic β cells, resulting in insulin deficiency and hyperglycaemia. In 2007, it was reported that 437,500 children were affected by T1D worldwide
More on Wikipedia
More on Sciencestage.com
More on Answers.com
More on Pubmed
More on answers.yahoo.com
News
- Type 1 Diabetes Treatment Disappoints in Trial
Title: Type 1 Diabetes Treatment Disappoints in Trial Category: Health News Created: 2/1/2012 6:06:00 PM Last Editorial Review: 2/2/2012 - Novo Nordisk Establishes Type 1 Diabetes R&D Center in Seattle
PRINCETON, N.J., Jan. 23, 2012 /PRNewswire/ -- Novo Nordisk (NYSE:NVO - News) announced today that the company will establish a type 1 diabetes research and development center in Seattle, Wash., U.S. The new ... - 4th Annual T1D Connections Retreat held Saturday
Anyone with a connection to Type 1 Diabetes is invited to take part in the 4th Annual T1D Connections Retreat. - Novel Stem Cell Treatment May Hold Promise for Type 1 Diabetes
WEDNESDAY, Jan. 11 (HealthDay News) -- A new type of stem cell treatment for people with type 1 diabetes appears to help re-educate rogue immune system cells, which allows cells in the pancreas to start producing insulin again. - Why Is Type 1 Diabetes Rising Worldwide?
We’ve gotten sadly accustomed by now to warnings about obesity and its effect on health: joint damage, heart disease, stroke, diabetes and its complications such as blindness and amputation. We almost take for granted that as obesity increases worldwide, diabetes will also, and it is. - Collaboration advances type 1 diabetes care research
(Medical Xpress) -- A study found that children with Type 1 diabetes experienced less time in deep sleep than children without diabetes, resulting in higher glucose levels, reduced quality of life and lower grades. - La Jolla Institute Scientist Takes Quest to Conquer Type 1 Diabetes to the Next Level
La Jolla Institute scientist Matthias von Herrath, M.D., a world leader in basic research on type 1 diabetes, has long dreamed of seeing his discoveries translated into new therapies to better treat this serious and chronic disorder. Dr. von Herrath may soon get his chance as head of a new translational type 1 diabetes center to be opened in Seattle in 2012 by Novo Nordisk, a global healthcare ... - Seasonal changes may influence the efficacy of vaccination against diabetes
The development of a medicine for patients with type 1 diabetes mellitus, based on autoantigen GAD65, received a setback following crucial clinical phase three trials that failed to show significant effects. One possible explanation may be seasonal variations in the immune system, claim those responsible for the study that was published in the New England Journal of Medicine. - La Jolla Institute researchers identify pivotal immune cell in Type 1 diabetes in humans
( La Jolla Institute for Allergy and Immunology ) Researchers at the La Jolla Institute for Allergy & Immunology have proven -- for the first time in human tissues -- the specific immune system T cells which trigger the destruction of Type 1 diabetes in the pancreas. The finding is an important advance that verifies in humans several important disease characteristics shown in mouse studies and ... - Study Points to Possible Cure of Type 1 Diabetes
About 1 in every 400 people suffers from type 1 diabetes, and that number continues to grow nationwide. A new study underway in Salt Lake City is offering hope to those who struggle with the disease.
